Cytokinetics
Presence
Cytokinetics is one of the...
Cytokinetics is a company listed under the stock ticker CYTK (US).
Executives
View the org chart displaying its 43 main executives
Most searched biographies at Cytokinetics
- Robert Blum, President, Chief Executive Officer, Director
- Lynne Parshall, Director
- Muna Bhanji, Director
Popular executive movements at Cytokinetics
- Sung Lee will join the company as Chief Financial Officer on May 8, 2024 (posted on April 29 2024).
- Jaw Ching, Senior Vice President and Chief Financial Officer, will leave the company on Feb. 23, 2024 (posted on February 5 2024).
Create your alert
to follow the executive moves at Cytokinetics.
Biotechnology
Cytokinetics has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by Cytokinetics
- Cytokinetics Announces Fourth Annual Communications Fellowship Grant Program Call for Proposals | Cytokinetics, Inc.
- Cytokinetics to Host Analyst & Investor Day on October 7, 2021 | Cytokinetics, Inc.
- Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF Presented in Late Breaking Clinical Trial Session at the HFSA Annual Scientific Meeting | Cytokinetics, Inc.
- Cytokinetics to Participate in September Investor Conferences | Cytokinetics, Inc.
- Cytokinetics to Host Investor Call and Webcast to Discuss the Full Results From Redwood-HCM at the HFSA Annual Scientific Meeting | Cytokinetics, Inc.
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Cytokinetics, Inc.
- Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF to Be Presented in Late Breaking Clinical Trials Session at the HFSA Annual Scientific Meeting | Cytokinetics, Inc.
- Reldesemtiv Effects Maintained in ALS When Used With Rilutek, Radicava, New Trial Analysis Shows
- Reldesemtiv Earns FDA’s Orphan Drug Designation for ALS Treatment
- Reldesemtiv Wins ALS Treatment Orphan Drug Designation From EMA
- View more press releases Close
Social media about Cytokinetics
- Cytokinetics on Wikipedia, Google News & Yahoo Finance
- Cytokinetics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Robert Blum 
Call Cytokinetics at +1 650...
